Hyperplasia of tonsils and adenoids in children
Conditions
Interventions
Control group:Fentanyl 4 µg/kg group (C group)
Experimental group:Affentanil 20 µg/kg groups (E1 group)
Experimental group:Affentanil 30µg/kg groups ( E2 group)
Experimental group:Affentanil 40µg/kg groups ( E3 group)
Sponsors
Yijishan Hospital of Wannan Medical College
Eligibility
Sex/Gender
All
Age
5 Years to 10 Years
Inclusion criteria
Inclusion criteria: 1) Age 5-10 years old, gender is not limited; 2) Weight between 14-28kg; 3) The ASA score is I or II; 4) Patients with complete clinical data who intend to undergo tonsillectomy or adenoidectomy; 5) Clearly understand and voluntarily participate in the study, and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1) Children with mental illness; 2) Children with congenital heart disease, liver and kidney dysfunction; 3) Children with respiratory diseases such as asthma; 4) Children with special constitutions, children with allergies, and those with a history of malignant hyperthermia in the family;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| mean arterial pressure, MAP;heart rate, HR;SpO2;Airway pressure;PAED score;FLACC score;Duration of surgery, time to anesthesia, time to extubation (time to stop propofol and refentanil pumping to time to remove the catheter), time to wake up, time to stay in the PACU;PAB score;Alderete score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Use of propofol, refentanil, cis-atracurium, and other adjunctive medications;Conditions with medications such as analgesia or antiemetics;The number of occurrences of bradycardia, hypoxemia, hypotension, hypertension, airway spasm, increased airway pressure, choking, nausea and vomiting was recorded; | — |
Countries
Chian
Contacts
Public ContactYongquan Chen
Yijishan Hospital of Wannan Medical College
Outcome results
None listed